NCT05291845 2025-06-12
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Zagazig University
Phase 2 Recruiting
Clinical Trials
25 trialsNCT05799157 2025-05-08
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
Veradermics, Inc.
Phase 2 Completed
NCT03487549 2024-11-27
COVE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT03981822 2024-11-27
CARE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT05896215 2024-09-27
OM202JP Clinical Study of KNP2002
KinoPharma Inc.
Phase 2 Completed
NCT04278573 2024-04-30
Intralesional Vitamin D Injection for Treatment of Common Warts
Mayo Clinic
Phase 2 Completed
NCT05877313 2024-04-17
Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)
Sanotize Research and Development corp.
Phase 2 Completed
NCT01796795 2023-09-14
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
G&E Herbal Biotechnology Co., LTD
Phase 2 Suspended
NCT01757392 2021-02-04
Candin Safety & Efficacy Study for the Treatment of Warts
Nielsen BioSciences, Inc.
Phase 2 Completed
NCT04399577 2020-05-27
Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts
Zagazig University
Phase 2 Completed
NCT02393417 2019-06-04
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Nielsen BioSciences, Inc.
Phase 2 Completed
NCT01286441 2019-05-29
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts
ViroXis Corporation
Phase 2 Completed
NCT03210337 2019-05-01
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT03278028 2019-04-09
A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT02669862 2018-12-07
A Study of A-101 Solution in Subjects With Common Warts.
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT02640820 2018-02-23
Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyproneâ„¢) on the Clearance of Verruca Vulgaris (Common Warts)
RXi Pharmaceuticals, Corp.
Phase 2 Unknown
NCT02798419 2016-08-16
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Dr. Reddys Laboratories, SA
Phase 2 Completed
NCT02483455 2016-03-09
ALC-919 For The Treatment Of Common Warts
Veloce BioPharma LLC
Phase 2 Completed
NCT00454181 2011-09-16
Treatment of Oral Warts in HIV+ Patients
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Phase 2 Completed
NCT00644579 2008-03-27
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
NatImmune A/S
Phase 2 Unknown
NCT00114920 2007-02-19
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00115141 2007-02-19
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00116662 2007-02-19
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00116675 2007-02-19
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00117923 2007-02-19
Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed